https://pmc.ncbi.nlm.nih.gov/articles/PMC2694001/
Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops - PMC
Olopatadine hydrochloride exerts a wide range of pharmacological actions such as histamine H1 receptor antagonist action, chemical mediator suppressive action,...
allergic conjunctivitisolopatadine hydrochlorideeye dropstreatmentpmc
https://www.business-standard.com/amp/markets/capital-market-news/glenmark-launches-olopatadine-hydrochloride-ophthalmic-solution-124081900104_1.html
Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution | Capital Market News - Business...
Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC); compare to the active ingredient in...
capital market newsolopatadine hydrochlorideophthalmic solutionglenmarklaunches
https://pmc.ncbi.nlm.nih.gov/articles/PMC5472412/
Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in...
Two individual phase 3 conjunctival allergen challenge (CAC) studies of similar design have assessed the efficacy and safety of olopatadine hydrochloride (HCl)...